Zobrazeno 1 - 10
of 77
pro vyhledávání: '"King H, Lam"'
Autor:
Müjde Durmaz, Otto Visser, Eduardus F. M. Posthuma, Rolf E. Brouwer, Djamila E. Issa, Daphne de Jong, King H. Lam, Nicole M. A. Blijlevens, Josée M. Zijlstra, Martine E. D. Chamuleau, Pieternella J. Lugtenburg, Marie José Kersten, Avinash G. Dinmohamed
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 3, Pp 1-11 (2022)
Abstract It is unclear whether survival in diffuse large B-cell lymphoma (DLBCL) continues to increase in an era where rituximab-containing chemotherapy reigns for almost two decades. Therefore, we evaluated trends in primary therapy and relative sur
Externí odkaz:
https://doaj.org/article/7115e3dd9f164bb78f75d59e6460bd0e
Autor:
Eline A. M. Zijtregtop, Ilse Tromp, Rana Dandis, Christian M. Zwaan, King H. Lam, Friederike A. G. Meyer-Wentrup, Auke Beishuizen
Publikováno v:
Pathology and Oncology Research, Vol 28 (2022)
Immunohistochemical markers are associated with treatment outcome in adults with classical Hodgkin Lymphoma (cHL). Studies in children are scarce and inconsistent. We investigated in 67 children with cHL, whether the expression of CD15, CD30, PAX5, P
Externí odkaz:
https://doaj.org/article/ebdc61ab90cd4171baba6409c5905056
Autor:
Jan Jacques Michiels, Fibo Ten Kate, King H. Lam, Wilfried Schroyens, Zwi Berneman, Hendrik De Raeve
Publikováno v:
Turkish Journal of Hematology, Vol 31, Iss 3, Pp 239-254 (2014)
OBJECTIVE: The prefibrotic stages of JAK2V617F essential thrombocythemia (ET) and JAK2V617F polycythemia vera (PV) can easily be diagnosed clinically without use of bone marrow biopsy histology. We assessed the 2008 WHO and European Clinical, Molecul
Externí odkaz:
https://doaj.org/article/8181e14111e84bf1bbe0d9c8d49c9f6b
Autor:
Boaz Lopuhaä, King H. Lam, Robert M. Verdijk, Jelle R. Miedema, Johan M. Kros, Willem A. Dik, Jasper van Bommel, Jan H. von der Thüsen
Publikováno v:
Journal of Hematopathology, 14(1), 79-83. Springer-Verlag
Journal of Hematopathology
Journal of Hematopathology
The clinical features of COVID-19 have a considerable range from a mild illness to severe disease. Underlying pathophysiological mechanisms of the rapidly progressive, and often fatal, pulmonary disease frequently observed in COVID-19 need to be eluc
Autor:
Miriam Beusink, Marjanka K. Schmidt, King H. Lam, Annegien Broeks, Folkert J. van Kemenade, Susanne Rebers
Publikováno v:
Biopreservation and Biobanking, 20(1), 67-74. Mary Ann Liebert Inc.
Residual biospecimens that are stored in hospitals' diagnostic specimen archives can be used for scientific research under strict legal and ethical regulations. In the Netherlands, a Code of Conduct governs responsible secondary use of residual biosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c7b660bef5f5709c45333d14f700338
https://pure.eur.nl/en/publications/c0e5fe2a-8072-44e1-9a3b-c38d4c93dd50
https://pure.eur.nl/en/publications/c0e5fe2a-8072-44e1-9a3b-c38d4c93dd50
Autor:
Fleur A. de Groot, Ruben A. L. de Groen, Anke van den Berg, Patty M. Jansen, King H. Lam, Pim G. N. J. Mutsaers, Carel J. M. van Noesel, Martine E. D. Chamuleau, Wendy B. C. Stevens, Jessica R. Plaça, Rogier Mous, Marie José Kersten, Marjolein M. W. van der Poel, Thomas Tousseyn, F. J. Sherida H. Woei-a-Jin, Arjan Diepstra, Marcel Nijland, Joost S. P. Vermaat
Publikováno v:
Cancers, 14(8):1857. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 14(8). MDPI
de Groot, F A, de Groen, R A L, van den Berg, A, Jansen, P M, Lam, K H, Mutsaers, P G N J, van Noesel, C J M, Chamuleau, M E D, Stevens, W B C, Plaça, J R, Mous, R, Kersten, M J, van der Poel, M M W, Tousseyn, T, Woei-A-jin, F J S H, Diepstra, A, Nijland, M & Vermaat, J S P 2022, ' Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma : A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach ', Cancers, vol. 14, no. 8, 1857 . https://doi.org/10.3390/cancers14081857
Cancers, 14, 8
Cancers, 14
Cancers, 14(8). MDPI
de Groot, F A, de Groen, R A L, van den Berg, A, Jansen, P M, Lam, K H, Mutsaers, P G N J, van Noesel, C J M, Chamuleau, M E D, Stevens, W B C, Plaça, J R, Mous, R, Kersten, M J, van der Poel, M M W, Tousseyn, T, Woei-A-jin, F J S H, Diepstra, A, Nijland, M & Vermaat, J S P 2022, ' Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma : A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach ', Cancers, vol. 14, no. 8, 1857 . https://doi.org/10.3390/cancers14081857
Cancers, 14, 8
Cancers, 14
Gene-expression profiling (GEP) is used to study the molecular biology of lymphomas. Here, advancing insights from GEP studies in diffuse large B-cell lymphoma (DLBCL) lymphomagenesis are discussed. GEP studies elucidated subtypes based on cell-of-or
Autor:
Wilhelmina M C Timmermans, Jan A M van Laar, Tim B van der Houwen, Lieke S J Kamphuis, Sophinus J W Bartol, King H Lam, Rob J Ouwendijk, Miles P Sparrow, Peter R Gibson, P Martin van Hagen, Menno C van Zelm
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0160103 (2016)
B-cell depletion can improve a variety of chronic inflammatory diseases, but does not appear beneficial for patients with Crohn's disease.To elucidate the involvement of B cells in Crohn's disease, we here performed an 'in depth' analysis of intestin
Externí odkaz:
https://doaj.org/article/404305960c5d4b79bf187c880e8aa316
Autor:
Coreline N. Burggraaff, Gregor Verhoef, Otto S. Hoekstra, Marie José Kersten, Lidwine W. Tick, Mels Hoogendoorn, Margreet Oosterveld, Daphne de Jong, Nicole C. H. P. van der Burg-de Graauw, Marinus van Marwijk Kooy, Matthijs H Silbermann, Aart Beeker, Marjolein van der Poel, Bart de Keizer, Eva de Jongh, Jeanette K. Doorduijn, Harry R. Koene, Thomas Stauffer Larsen, Memis Y Bilgin, Lara H Böhmer, Joost W. J. van Esser, Peter de Nully Brown, Marcel Nijland, Maria B.L. Leijs, J.F.M. Pruijt, Anne I.J. Arens, Josée M Zijlstra-Baalbergen, Pieternella J. Lugtenburg, Kon-Siong G. Jie, Rolf E. Brouwer, King H. Lam, Rob Fijnheer, Bronno van der Holt, Francesco d'Amore
Publikováno v:
Journal of Clinical Oncology, 38(29), 3377-3387. American Society of Clinical Oncology
Journal of Clinical Oncology, 38(29). American Society of Clinical Oncology
Lugtenburg, P J, De Nully Brown, P, Van der Holt, B, D'Amore, F A, Koene, H R, De Jongh, E, Fijnheer, R, Van Esser, J W, Bohmer, L H, Pruijt, J F, Verhoef, G E, Hoogendoorn, M, Bilgin, M Y, Nijland, M, Van der Burg-De Graauw, N C, Oosterveld, M, Jie, K S G, Larsen, T S, Van der Poel, M W, Leijs, M B, Silbermann, M H, Van Marwijk Kooy, M, Beeker, A, Kersten, M J, Doorduijn, J K, Tick, L W, Brouwer, R E, Lam, K H, Burggraaff, C N, De Keizer, B, Arens, A I, De Jong, D, Hoekstra, O S & Zijlstra-Baalbergen, J M 2020, ' Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma : A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84) ', Journal of Clinical Oncology, vol. 38, no. 29, pp. 3377-3387 . https://doi.org/10.1200/JCO.19.03418
Journal of clinical oncology, 38(29), 3377-3387. American Society of Clinical Oncology
Lugtenburg, P J, De Nully Brown, P, Van der Holt, B, D'Amore, F A, Koene, H R, De Jongh, E, Fijnheer, R, Van Esser, J W, Bohmer, L H, Pruijt, J F, Verhoef, G E, Hoogendoorn, M, Bilgin, M Y, Nijland, M, Van der Burg-De Graauw, N C, Oosterveld, M, Jie, K S G, Larsen, T S, Van der Poel, M W, Leijs, M B, Silbermann, M H, Van Marwijk Kooy, M, Beeker, A, Kersten, M J, Doorduijn, J K, Tick, L W, Brouwer, R E, Lam, K H, Burggraaff, C N, De Keizer, B, Arens, A I, De Jong, D, Hoekstra, O S & Zijlstra-Baalbergen, J M 2020, ' Rituximab-chop with early rituximab intensification for diffuse large b-cell lymphoma : A randomized phase iii trial of the hovon and the nordic lymphoma group (hovon-84) ', Journal of Clinical Oncology, vol. 38, no. 29, pp. 3377-3387 . https://doi.org/10.1200/JCO.19.03418
Journal of Clinical Oncology, 38, 29, pp. 3377-3387
Journal of Clinical Oncology, 38(29), 3377-3387. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 38(29):38, 3377-3387. American Society of Clinical Oncology
Journal of Clinical Oncology, 38, 3377-3387
Lugtenburg, P J, de Nully Brown, P, van der Holt, B, D'Amore, F A, Koene, H R, de Jongh, E, Fijnheer, R, van Esser, J W, Böhmer, L H, Pruijt, J F, Verhoef, G E, Hoogendoorn, M, Bilgin, M Y, Nijland, M, van der Burg-de Graauw, N C, Oosterveld, M, Jie, K-S G, Larsen, T S, van der Poel, M W, Leijs, M B, Silbermann, M H, van Marwijk Kooy, M, Beker, A, Kersten, M J, Doorduijn, J K, Tick, L W, Brouwer, R E, Lam, K H, Burggraaff, C N, de Keizer, B, Arens, A I, de Jong, D, Hoekstra, O S & Zijlstra-Baalbergen, J M 2020, ' Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84) ', Journal of Clinical Oncology, vol. 38, no. 29, 38, pp. 3377-3387 . https://doi.org/10.1200/JCO.19.03418, https://doi.org/DOI: 10.1200/JCO.19.03418
Journal of Clinical Oncology, 38(29). American Society of Clinical Oncology
Lugtenburg, P J, De Nully Brown, P, Van der Holt, B, D'Amore, F A, Koene, H R, De Jongh, E, Fijnheer, R, Van Esser, J W, Bohmer, L H, Pruijt, J F, Verhoef, G E, Hoogendoorn, M, Bilgin, M Y, Nijland, M, Van der Burg-De Graauw, N C, Oosterveld, M, Jie, K S G, Larsen, T S, Van der Poel, M W, Leijs, M B, Silbermann, M H, Van Marwijk Kooy, M, Beeker, A, Kersten, M J, Doorduijn, J K, Tick, L W, Brouwer, R E, Lam, K H, Burggraaff, C N, De Keizer, B, Arens, A I, De Jong, D, Hoekstra, O S & Zijlstra-Baalbergen, J M 2020, ' Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma : A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84) ', Journal of Clinical Oncology, vol. 38, no. 29, pp. 3377-3387 . https://doi.org/10.1200/JCO.19.03418
Journal of clinical oncology, 38(29), 3377-3387. American Society of Clinical Oncology
Lugtenburg, P J, De Nully Brown, P, Van der Holt, B, D'Amore, F A, Koene, H R, De Jongh, E, Fijnheer, R, Van Esser, J W, Bohmer, L H, Pruijt, J F, Verhoef, G E, Hoogendoorn, M, Bilgin, M Y, Nijland, M, Van der Burg-De Graauw, N C, Oosterveld, M, Jie, K S G, Larsen, T S, Van der Poel, M W, Leijs, M B, Silbermann, M H, Van Marwijk Kooy, M, Beeker, A, Kersten, M J, Doorduijn, J K, Tick, L W, Brouwer, R E, Lam, K H, Burggraaff, C N, De Keizer, B, Arens, A I, De Jong, D, Hoekstra, O S & Zijlstra-Baalbergen, J M 2020, ' Rituximab-chop with early rituximab intensification for diffuse large b-cell lymphoma : A randomized phase iii trial of the hovon and the nordic lymphoma group (hovon-84) ', Journal of Clinical Oncology, vol. 38, no. 29, pp. 3377-3387 . https://doi.org/10.1200/JCO.19.03418
Journal of Clinical Oncology, 38, 29, pp. 3377-3387
Journal of Clinical Oncology, 38(29), 3377-3387. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 38(29):38, 3377-3387. American Society of Clinical Oncology
Journal of Clinical Oncology, 38, 3377-3387
Lugtenburg, P J, de Nully Brown, P, van der Holt, B, D'Amore, F A, Koene, H R, de Jongh, E, Fijnheer, R, van Esser, J W, Böhmer, L H, Pruijt, J F, Verhoef, G E, Hoogendoorn, M, Bilgin, M Y, Nijland, M, van der Burg-de Graauw, N C, Oosterveld, M, Jie, K-S G, Larsen, T S, van der Poel, M W, Leijs, M B, Silbermann, M H, van Marwijk Kooy, M, Beker, A, Kersten, M J, Doorduijn, J K, Tick, L W, Brouwer, R E, Lam, K H, Burggraaff, C N, de Keizer, B, Arens, A I, de Jong, D, Hoekstra, O S & Zijlstra-Baalbergen, J M 2020, ' Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84) ', Journal of Clinical Oncology, vol. 38, no. 29, 38, pp. 3377-3387 . https://doi.org/10.1200/JCO.19.03418, https://doi.org/DOI: 10.1200/JCO.19.03418
PURPOSE Immunochemotherapy with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) has become standard of care for patients with diffuse large B-cell lymphoma (DLBCL). This randomized trial assessed whether rituximab i
Autor:
Konnie M. Hebeda, Hendrik De Raeve, Francisca Valster, Vincent Potter, J. J. Michiels, King H. Lam, K. Schelfout, Wilfried Schroyens
Publikováno v:
Acta Scientific Medical Sciences. 4:99-121
Autor:
Müjde, Durmaz, Otto, Visser, Eduardus F M, Posthuma, Rolf E, Brouwer, Djamila E, Issa, Daphne, de Jong, King H, Lam, Nicole M A, Blijlevens, Josée M, Zijlstra, Martine E D, Chamuleau, Pieternella J, Lugtenburg, Marie José, Kersten, Avinash G, Dinmohamed
Publikováno v:
Blood cancer journal. 12(3)
It is unclear whether survival in diffuse large B-cell lymphoma (DLBCL) continues to increase in an era where rituximab-containing chemotherapy reigns for almost two decades. Therefore, we evaluated trends in primary therapy and relative survival (RS